ICleanse develops chemical-free disinfection stations used in the medical, food, education, and other markets.
iCleanse has raised $1.0M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2023.
iCleanse's investors include Connecticut Innovations, Enhanced Capital Partners, David Engelhardt.
iCleanse is headquartered in Avon, United States.
ICleanse develops chemical-free disinfection stations used in the medical, food, education, and other markets.
iCleanse is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iCleanse — Funding & Investors." VCBacked, October 6, 2023, https://www.vcbacked.co/company/icleanse. Accessed September 30, 2026.
VCBacked. (2023). iCleanse — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/icleanse
{{cite web |title=iCleanse — Funding & Investors |url=https://www.vcbacked.co/company/icleanse |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated